Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 07, 2016 08:30 ET | Source: Dyadic International, Inc.

Dyadic International, Inc. Announces Research and Development Agreement to Further Advance Its Proprietary C1 Fungal Strain for Biopharmaceutical Development & Production

JUPITER, Fla., Sept. 07, 2016 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on the development and large scale manufacture of low...
August 16, 2016 11:11 ET | Source: Dyadic International, Inc.

Dyadic International, Inc. Appoints Arindam Bose, Ph.D., Distinguished Life Sciences Executive, to Board of Directors

JUPITER, Fla., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on the development and large scale manufacture of low...
August 11, 2016 16:15 ET | Source: Dyadic International, Inc.

Dyadic International Reports Second Quarter 2016 Financial Results

JUPITER, Fla., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focusing on further improving and leveraging the patented and...
August 11, 2016 14:51 ET | Source: Dyadic International, Inc.

Dyadic International Board Approves a Reverse Stock Split Subject to Obtaining Shareholder Approval

JUPITER, Fla., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company") (OTCQX:DYAI), a global biotechnology company focused on further improving and leveraging the...
August 08, 2016 08:30 ET | Source: Dyadic International, Inc.

Dyadic International Reports the Termination of Agreement With Sanofi Pasteur

JUPITER, Fla., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI) announced today the termination of its Proof of Concept, Exclusive Option & Technology...
August 02, 2016 17:11 ET | Source: Dyadic International, Inc.

Dyadic International to Announce Second Quarter 2016 Financial Results and Host Conference Call on Thursday, August 11, 2016

JUPITER, Fla., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company announced today that it will report its financial results for...
May 12, 2016 16:05 ET | Source: Dyadic International, Inc.

Dyadic International Reports First Quarter 2016 Financial Results

JUPITER, Fla., May 12, 2016 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and leveraging the patented and...
April 28, 2016 09:04 ET | Source: Dyadic International, Inc.

Dyadic International to Announce First Quarter 2016 Financial Results and Host Conference Call on Thursday, May 12, 2016

JUPITER, Fla., April 28, 2016 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company announced today that it will report its financial results for...
April 06, 2016 16:05 ET | Source: Dyadic International, Inc.

Dyadic International Announces It Has Reached a Settlement With One of the Two Remaining Defendant Law Firms in Its Professional Liability Litigation

JUPITER, Fla., April 06, 2016 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic") (OTCQX:DYAI), today announced it has reached a confidential settlement with one of the two remaining...
March 29, 2016 16:05 ET | Source: Dyadic International, Inc.

Dyadic International Reports 2015 Annual Financial Results

- Dyadic Closes $75 Million DuPont Transaction on December 31, 2015 -- Dyadic Retains C1 License to Focus in Pharmaceutical Sector -- All Debt Has Been Repaid or Converted into Dyadic Common Stock...